Positron emission tomography–guided therapy of aggressive non-Hodgkin lymphomas (PETAL): a multicenter, randomized phase III trial

…, S Wilop, T Krohn, J Holzinger… - Journal of Clinical …, 2018 - ascopubs.org
Purpose Interim positron emission tomography (PET) using the tracer, [ 18 F]fluorodeoxyglucose,
may predict outcomes in patients with aggressive non-Hodgkin lymphomas. We …

Improvement in coronary flow reserve determined by positron emission tomography after 6 months of cholesterol-lowering therapy in patients with early stages of …

…, G Notohamiprodjo, U Gleichmann, J Holzinger… - Circulation, 1999 - Am Heart Assoc
Background—Early stages of coronary atherosclerosis are characterized by a mainly
functional impairment of coronary vasodilator capacity under the impact of such risk factors as …

Effect of cardiac resynchronization therapy on global and regional oxygen consumption and myocardial blood flow in patients with non-ischaemic and ischaemic …

…, A Kammeier, P Wielepp, J Holzinger… - European heart …, 2005 - academic.oup.com
Aims We studied the effects of cardiac resynchronization therapy (CRT) on global and
regional myocardial oxygen consumption (MVO 2 ) and myocardial blood flow (MBF) in non-…

Interim PET evaluation in diffuse large B-cell lymphoma using published recommendations: comparison of the Deauville 5-point scale and the ΔSUVmax method

…, A Hertel, T Krohn, J Holzinger… - Journal of Nuclear …, 2021 - Soc Nuclear Med
The value of interim 18 F-FDG PET/CT (iPET)–guided treatment decisions in patients with
diffuse large B-cell lymphoma (DLBCL) has been the subject of much debate. This …

Six versus eight doses of rituximab in patients with aggressive B cell lymphoma receiving six cycles of CHOP: results from the “Positron Emission Tomography-Guided …

…, G Prange-Krex, M Griesshammer, J Holzinger… - Annals of …, 2019 - Springer
Standard first-line treatment of aggressive B cell lymphoma comprises six or eight cycles of
cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) plus eight doses of …

Global and regional myocardial oxygen consumption and blood flow in severe cardiomyopathy with left bundle branch block

…, A Kammeier, P Wielepp, J Holzinger… - European journal of …, 2005 - Wiley Online Library
Objective: In patients with dilated cardiomyopathy (DCM), left bundle branch block (LBBB) is
a common finding. The characteristic feature is an asynchronous septal wall motion and …

Positron Emission Tomography (PET) guided therapy of Aggressive lymphomas-interim PET-based outcome prediction and treatment changes in patients with B cell …

…, G Prange-Krex, M Griesshammer, J Holzinger… - 2016 - ashpublications.org
Introduction: The PETAL trial is a multicenter randomized controlled study for patients with
aggressive lymphomas of diverse histologies (EudraCT 2006-001641-33, NCT00554164). In …

Successful use of cardiac allograft from serotonin antagonist intoxication

G Tenderich, A Dagge, U Schulz, J Holzinger… - …, 2001 - journals.lww.com
Background. Compromised organ donors are generally not accepted for heart transplantation
(HT) despite the increasing number of critically ill patients on the waiting lists. By …

Pontocerebellar hypoplasia type 1: Clinical spectrum and relevance of EXOSC3 mutations

…, L Van Maldergem, M Schiff, A Holzinger… - Neurology, 2013 - AAN Enterprises
Objectives: Pontocerebellar hypoplasia with spinal muscular atrophy, also known as PCH1,
is a group of autosomal recessive disorders characterized by generalized muscle weakness …

[HTML][HTML] Atmospheric VOC measurements at a High Arctic site: characteristics and source apportionment

…, JK Nųjgaard, R Holzinger… - Atmospheric …, 2021 - acp.copernicus.org
There are few long-term datasets of volatile organic compounds (VOCs) in the High Arctic.
Furthermore, knowledge about their source regions remains lacking. To address this matter, …